Biotech Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA November 25, 2024
Biotech Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset November 23, 2024
Biotech Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA November 22, 2024
Biotech InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation November 21, 2024
Biotech Thryv Therapeutics Announces the Appointment of Esteemed Executive Leader Amy Sehnert, MD, as Chief Medical Officer November 20, 2024
Biotech Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain November 19, 2024
Biotech Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE November 18, 2024
Biotech BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 November 17, 2024
Search
Biotech
November 26, 2024
November 25, 2024
November 24, 2024
November 23, 2024
November 22, 2024
November 21, 2024
November 20, 2024
November 19, 2024
November 18, 2024
November 17, 2024
